ABERRANT EXPRESSION OF GLUCAGON RECEPTORS IN ADRENAL GLANDS OF A PATIENT WITH CUSHING'S SYNDROME AND ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA

作者：de Miguel Valeria; Ana Redal Maria; Lorena Viale Maria; Kahan Mariano; Glerean Mariela; Beskow Axel; Fainstein Day Patricia

来源：Medicina-Buenos Aires, 2010, 70(3): 254-256.

• Cushing's syndrome
• adrenocorticotropin
• ACTH-independent bilateral macronodular adrenal hyperplasia (AIMAH)
• glucagon receptor
• illicit receptor

Adrenocorticotropin (ACTH) independent bilateral macronodular adrenal hyperplasia (AIMAH) is a rare cause of Cushing's syndrome, characterized by bilateral adrenal lesions and excess cortisol production despite ACTH suppression. Cortisol synthesis is produced in response to abnormal activation of G-protein-coupled receptors, such as gastric inhibitory peptide, vasopressin, beta adrenergic agonists, LH/hCG and serotonin receptors. The aim of this study was to analyze the expression of glucagon receptors in adrenal glands from an AIMAH patient. A patient with ACTH-independent Cushing's syndrome and bilateral macronodular adrenal hyperplasia was screened for altered activation of adrenal receptors by physiological (mixed meal) and pharmacological (gonadotrophin releasing hormone, ACTH and glucagon) tests. The results showed abnormally high levels of serum cortisol after stimulation with glucagon. Hypercortisolism was successfully managed with ketoconazole treatment. Interestingly, a 4-month treatment with a somatostatin analogue (octreotide) was also able to reduce cortisol secretion. Finally, Cushing's syndrome was cured after bilateral adrenalectomy. Abnormal mRNA expression for glucagon receptor in the patient's adrenal glands was observed by Real-Time PCR procedure. These results strongly suggest that the mechanism of AIMAH causing Cushing's syndrome in this case involves the illicit activation of adrenal glucagon receptors. This is the first case reported of AIMAH associated with ectopic glucagon receptors.

• 出版日期2010